Article

The History of the Delivery of Insulin

Former ADA President Gerald Bernstein discusses the history of and recent advances in the delivery of insulin.

Gerald Bernstein, former president of the American Diabetes Association and now Generex’s VP of Medical Affairs, discusses the history of and recent advances in the delivery of insulin.

Click here to access this third party resource.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Related Content
David Tak Wai Lui I Credit: ResearchGate
December 20th 2024

Study Shows a U-Shaped Association Between HDL-C, Major Adverse Cardiovascular Events

Chelsie Derman
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
December 16th 2024

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Aldosterone Dysregulation Linked to Notable Risk of Hypertension | Image Credit: CMHC
December 14th 2024

Aldosterone Dysregulation Linked to Notable Risk of Hypertension

Connor Iapoce
Irl Hirsch, MD | Credit: University of Washington
December 12th 2024

Diabetes Dialogue: Celebrating 25 Years of CGM, with Irl Hirsch, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Mifepristone Significantly Reduces HbA1c in Treatment Phase of CATALYST | Image Credit: LinkedIn
December 12th 2024

Mifepristone Notably Reduces HbA1c in Treatment Phase of CATALYST Trial

Connor Iapoce
Insulin Resistance Amplifies Risk of Colorectal Cancer Development | Image Credit: ResearchGate
December 12th 2024

Insulin Resistance Amplifies Risk of Colorectal Cancer Development

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.